Drugs / SARS-Cov-2 Vaccina(Vero Cell ) Inactivated
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05580159 Comparator | Oct 2022 → May 2023 | — | Stemirna Therapeutics | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SARS-Cov-2 Vaccina(Vero Cell ) Inactivated | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05580159 ↗ |
| Modality | Vaccine | “a homologous booster of an inactivated vaccine (BBIBP) in Laos.” PMID 38169790 ↗ Dec 2023 |
| Route | Intramuscular | “Route of Administration Intramuscular : injection Intramuscular” NCT05580159 ↗ |